Silicon Valley Bank Collapse Causes Reactions in Space Industry

The recent news of the collapse of Silicon Valley Bank (SVB) has sent shockwaves throughout the space industry. SVB was...

The recent collapse of Silicon Valley Bank (SVB) has caused a major disruption in the space industry. SVB, a major...

The recent collapse of Silicon Valley Bank (SVB) has sent shockwaves through the space industry. SVB had been a major...

The recent collapse of Silicon Valley Bank (SVB) has sent shockwaves through the space industry. SVB had been a major...

The recent collapse of Silicon Valley Bank (SVB) has sent shockwaves through the space industry. SVB was a major lender...

The year 2023 is set to be a pivotal one for late-stage technology and life sciences companies considering an initial...

The IPO market is an ever-changing landscape, and the uncertainty of the current market has made it difficult for late-stage...

As the world continues to navigate the economic and social impacts of the COVID-19 pandemic, many late-stage technology and life...

As the world continues to grapple with the economic and social effects of the COVID-19 pandemic, many late-stage technology and...

Airship AI, a leading artificial intelligence (AI) company, recently announced that it has signed a letter of intent for a...

Recent news has revealed that Airship AI, a leading artificial intelligence (AI) company, has signed a letter of intent with...

In a major development in the AI industry, Airship AI and BYTE have signed a letter of intent for a...

Corporation On April 8th, 2021, Airship AI, a leading provider of artificial intelligence (AI) solutions, announced that it had signed...

Airship AI, a leading artificial intelligence (AI) company, recently announced that it has signed a letter of intent with BYTE...

Systango Technologies, a leading software development company, is set to make its Initial Public Offering (IPO) in 2023. Investors who...

Services Systango Technologies, a leading technology company, is set to launch its Initial Public Offering (IPO) in 2023. The IPO...

Services Systango Technologies, a leading software development company, is set to make its Initial Public Offering (IPO) in 2023. The...

Agile Growth Corp. recently announced the redemption price for its publicly traded securities. The redemption price, which is set at...

Agile Growth Corp. recently announced the redemption price for its publicly offered securities. This is a significant milestone for the...

Agile Growth Corp. recently announced the redemption price for its publicly held Class A ordinary shares. This redemption price will...

Agile Growth Corp. (AGC) recently announced the redemption price for its Class A ordinary shares listed on Yahoo Finance. The...

The Divgi TorqTransfer Systems Initial Public Offering (IPO) in 2023 is an exciting opportunity for investors to get in on...

The Indian stock market has seen a surge in Initial Public Offerings (IPOs) in recent years, with many companies looking...

Sudarshan Pharma Limited Initial Public Offering Subscription Status – Now Open

Sudarshan Pharma Limited, a leading Indian pharmaceutical company, has recently opened its Initial Public Offering (IPO) subscription for public investors. This is the first time that the company is offering its shares to the public. The IPO subscription period will be open from June 14th to June 18th, 2021.

The IPO of Sudarshan Pharma Limited is a great opportunity for investors to participate in the growth of the company. The company is offering up to 12.5 crore equity shares at a price band of Rs. 517 to Rs. 518 per equity share. The minimum application amount is Rs. 5,000 and in multiples of Rs. 1 thereafter.

The company has a strong presence in the Indian pharmaceutical market and has a diversified product portfolio. It has a wide range of products including antibiotics, anti-infectives, anti-diabetics, vitamins and minerals, and other products. The company has a strong track record of delivering consistent performance over the years and has been successful in expanding its market share in the domestic market.

The proceeds from the IPO will be used by the company for various purposes such as repayment of debt, funding working capital requirements, and general corporate purposes. The company has also appointed SBI Capital Markets Limited and ICICI Securities Limited as the book running lead managers for the issue.

Investors can apply for the IPO through various modes such as ASBA (Application Supported by Blocked Amount) through their bank account, UPI (Unified Payments Interface), and other online platforms such as NSE Now, BSE Now, and Kite.

Overall, Sudarshan Pharma Limited’s IPO is a great opportunity for investors to participate in the growth of the company and benefit from its strong presence in the Indian pharmaceutical market. Investors should carefully evaluate all the risks associated with the IPO before investing.

Ai Powered Web3 Intelligence Across 32 Languages.